# EDGAR Filing Document

**Accession Number:** 0001948294
**File Stem:** 0001493152-25-015039
**Filing Date:** 2025-9
**Character Count:** 8146
**Document Hash:** e4cea0863c45080d3165e69044fc0566
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-015039.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0001493152-25-015039

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250926

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nature Wood Group Ltd
- **CENTRAL INDEX KEY:** 0001948294
- **STANDARD INDUSTRIAL CLASSIFICATION:** LUMBER & WOOD PRODUCTS (NO FURNITURE) [2400]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** AVENIDA DA AMIZADE NO.1287
- **STREET 2:** CHONG FOK CENTRO COMERCIAL,13 E
- **CITY:** MACAU S.A.R
- **PROVINCE COUNTRY:** N5
- **BUSINESS PHONE:** 852 60385546

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** AVENIDA DA AMIZADE NO.1287
- **STREET 2:** CHONG FOK CENTRO COMERCIAL,13 E
- **CITY:** MACAU S.A.R
- **PROVINCE COUNTRY:** N5

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Nature Wood Group Ltd
- **DATE OF NAME CHANGE:** 20220926

**NATURE WOOD GROUP LIMITED**

Avenida da Amizade no. 1287

Chong Fok Centro Comercial, 13 E

Macau S.A.R

**Via EDGAR**

September 26, 2025

Division of Corporation Finance

Office of Trade & Services

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attention: Ernest Greene

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anne McConnell

---

| | | |
|:---|:---|:---|
| **Re** | **:** | **Nature Wood Group Ltd (the "Company")** |
|  |  | **Form 20-F for the fiscal year ended December 31, 2024** |
|  |  | **Filed May 1, 2025** |
|  |  | **File No. 001-41796** |

---

Dear Mr. Greene and Ms. McConnell:

We hereby submit this letter in response to the comment letter of the staff of the Division of Corporation Finance (the "Staff") of the U.S. Securities and Exchange Commission (the "Commission") dated July 22, 2025 (the "Staff's Letter") with respect to the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2024 (the "Form 20-F").

In order to facilitate the review by Staff, each of the Staff's numbered comments from the Staff's Letter is set forth in bold text below, followed by the Company's response to each comment.

**<u>Form 20-F for the fiscal year ended December 31, 2024</u>**

**<u>Part I., page 1</u>**

● **Disclose you are not a Chinese operating company but a British Virgin Islands holding company that does not conduct operations, that operations are conducted by your subsidiaries, and that this structure involves unique risks to investors. Provide a cross-reference to the more detailed discussion of risks facing the company as a result of this structure.** 

● **Disclose the legal and operational risks associated with being based in or having the majority of operations in China. Your disclosure should make clear whether these risks could result in a material change in your operations and/or the value of your ordinary shares or could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. Your disclosure should address how recent statements and regulatory actions by China's government, such as those related to data security or anti-monopoly concerns, have or may impact the company's ability to conduct its business, accept foreign investments, or list on a U.S. or other foreign exchange.** 

● **Disclose the risks that your corporate structure and being based in or having the majority of operations in China pose to investors. In particular, describe the significant regulatory, liquidity, and enforcement risks with cross-references to the more detailed discussions of these risks. For example, specifically discuss risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance notice; and the risk that the Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in your operations and/or the value of your securities. Acknowledge any risks that any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.** 

● **Disclose each permission or approval that you or your subsidiaries are required to obtain from Chinese authorities to operate your business and to offer securities to foreign investors. State whether you or your subsidiaries are covered by permissions requirements from the China Securities Regulatory Commission (CSRC), Cyberspace Administration of China (CAC) or any other governmental agency that is required to approve your or your subsidiaries' operations, and state affirmatively whether you have received all requisite permissions or approvals and whether any permissions or approvals have been denied. Also, describe the consequences to you and your investors if you or your subsidiaries: (i) do not receive or maintain such permissions or approvals, (ii) inadvertently conclude that such permissions or approvals are not required, or (iii) applicable laws, regulations, or interpretations change and you are required to obtain such permissions or approvals in the future.** 

● **Provide a clear description of how cash is transferred through your organization. Disclose your intentions to distribute earnings or settle amounts owed under your operating structure. Quantify any cash flows and transfers of other assets by type that have occurred between the holding company and its subsidiaries, and the direction of transfer. Quantify any dividends or distributions that a subsidiary has made to the holding company and which entity made such transfer, and their tax consequences. Similarly quantify dividends or distributions made to U.S. investors, their source, and their tax consequences. Your disclosures should make it clear if no transfers, dividends, or distributions have been made to date by stating that fact. Also, describe any restrictions on foreign exchange and your ability to transfer cash between entities, across borders, and to U.S. investors. Describe any restrictions and limitations on your ability to distribute earnings from the company, including your subsidiaries, to the parent company and U.S. investors.** 

Response:

The Company acknowledges the Staff's comment and advises the Staff that it will revise its disclosure in future filings on Form 20-F to include, in the forepart of the filing under Part I in an Overview section, prominent disclosure regarding the legal and operational risks associated with China-based companies, similar to the disclosure provided in the Company's Form F-1 registration statement and updated for relevant subsequent events.

**<u>Item 19. Exhibits</u>**

**<u>Exhibit 13.1, page 77</u>**

**2.** **Please ensure future filings include the correct name of the CEO. The name in the forepart of the certification does not match the name of the current CEO and signer.** 

Response:

The Company acknowledges the Staff's comment and advises the Staff that it will ensure future filings correctly reflects the name of the Company's CEO.

Please reach Lawrence Venick, the Company's outside counsel at +852.5600.0188 if you would like additional information with respect to any of the foregoing. Thank you.

Sincerely,

---

| | |
|:---|:---|
| */s/ Hok Pan Se* | */s/ Hok Pan Se* |
| Name: | Hok Pan Se |
| Title: | Director |

---